Literature DB >> 20549250

Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease.

Bon Shoji1, Fusao Ikeda, Shin-ichi Fujioka, Haruhiko Kobashi, Tetsuya Yasunaka, Yasuhiro Miyake, Hidenori Shiraha, Akinobu Takaki, Kazuhiro Nouso, Yoshiaki Iwasaki, Kazuhide Yamamoto.   

Abstract

BACKGROUND: For patients with chronic hepatitis due to hepatitis B virus (HBV), factors predicting hepatocellular carcinoma (HCC) other than high levels of HBV-DNA and alanine aminotransferase (ALT) are needed to prevent HCC development, as many patients with chronic HBV infection fulfill these conditions. The purpose of this study was to clarify factors predictive of HCC development for those patients.
METHODS: The study was a systematic cohort analysis of 303 consecutive patients with hepatitis B e-antigen, receiving laparoscopic examination for assessment of liver disease. Laparoscopic, histological, and clinical characteristics were investigated as related to HCC development.
RESULTS: HCC occurred in 27 patients during a mean follow-up of 8.0 ± 5.0 years, at the age of 37-72 years. Significant associations with HCC development were shown for liver cirrhosis, histological activity grade, reddish markings, and older age. Multivariate analysis revealed that HCC development was strongly associated with older age and male gender (P = 0.002 and P = 0.043, respectively). HCC occurred more frequently in patients of age ≥30 years even with early stage than in patients of age <30 years (P = 0.031). Severe reddish markings, a laparoscopic finding of widespread parenchymal destruction, were highly associated with HCC development in patients of age ≥30 years at diagnosis (odds ratio = 1.67, P = 0.034), while histological activity grade and ALT level were not (P = 0.075 and P = 0.69, respectively).
CONCLUSIONS: HCC development is associated with older age, male gender, and liver cirrhosis. Reddish markings, rather than histological activity or ALT level, can be useful to predict HCC for HBV patients of age ≥30 years.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549250     DOI: 10.1007/s00535-010-0266-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  27 in total

1.  Prospective study of laparoscopic findings with regard to the development of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis.

Authors:  K Shiraki; A Shimizu; K Takase; A Suzuki; Y Tameda; T Nakano
Journal:  Gastrointest Endosc       Date:  2001-04       Impact factor: 9.427

2.  FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C.

Authors:  Masahiko Koda; Yoshiko Matunaga; Manri Kawakami; Yukihiro Kishimoto; Takeaki Suou; Yoshikazu Murawaki
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan.

Authors:  E Orito; T Ichida; H Sakugawa; M Sata; N Horiike; K Hino; K Okita; T Okanoue; S Iino; E Tanaka; K Suzuki; H Watanabe; S Hige; M Mizokami
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

Review 4.  Radiologic diagnosis of hepatocellular carcinoma.

Authors:  M S Peterson; R L Baron
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

Review 5.  Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions.

Authors:  M Kudo
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Superiority of laparoscopy compared to ultrasonography in diagnosis of widespread liver diseases.

Authors:  M Cardi; I A Muttillo; L Amadori; R Petroni; P Mingazzini; P Barillari; D Lisi; A Bolognese
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

7.  Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.

Authors:  Myron John Tong; Carlos Hsien; Leeyen Hsu; Hai-En Sun; Lawrence Mitchell Blatt
Journal:  Hepatology       Date:  2008-10       Impact factor: 17.425

8.  Peritoneoscopy as an aid in intravenous injection of indocyanine green (ICG).

Authors:  M Watanabe; H Hirakawa; S Ikeda; Y Umekawa; Y Takatori; Y Morita; K Ueki; T Matsura; K Ohgi; K Nishimura
Journal:  Endoscopy       Date:  1985-07       Impact factor: 10.093

9.  Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease.

Authors:  Hajime Sumi; Osamu Yokosuka; Naohiko Seki; Makoto Arai; Fumio Imazeki; Tomoko Kurihara; Tatsuo Kanda; Kenichi Fukai; Masaki Kato; Hiromitsu Saisho
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

10.  An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load.

Authors:  Yen Ngo; Yves Benhamou; Vincent Thibault; Patrick Ingiliz; Mona Munteanu; Pascal Lebray; Dominique Thabut; Rachel Morra; Djamila Messous; Frederic Charlotte; Françoise Imbert-Bismut; Dominique Bonnefont-Rousselot; Dominique Rousselot-Bonnefont; Joseph Moussalli; Vlad Ratziu; Thierry Poynard
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.